Phyto Chem (India) Share Price

State bond yields outpace AAA rated corporate bond yields for long tenors

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Solar91 Cleantech IPO to open on Dec 24; price band at Rs 185-195 per share

Front-running case: Sebi bans 9 entities, impounds Rs 21 cr illegal gains

IPO boom: Record Rs 1.6 trn raised in 2024; bigger gains expected in 2025

Pursuant to Regulation 23(9) of Listing Regulations please find enclosed disclosure of related party transactions on a consolidated basis for the half year ended September 30 2024.

With reference to the subject cited above we hereby inform that the Company has in compliance of Regulation 30 of the SEBI (LODR) Regulation 2015 approved the reappointment of Mr.Y. Nayudamma (DIN:00377721) as Managing Director of the Company at the 234th Board of Directors Meeting held on 13th November 2024 for a period of 3 years w.e.f 1st January 2025 to 31st December 2027.The above information is being given in terms of Para A Part A of Schedule III read with Regulation 30 of SEBI (LODR) Regulations 2015.

In furtherance to the Board Meeting Notice dated 06th November 2024 we wish to inform you that at the meeting of Board of Directors of M/s. Phyto Chem (India) Ltd. held today i.e. on 13th November 2024 the Board has inter-alia considered and approved the Unaudited Financial Results for the Second Quarter and half-year ended 30th September 2024. The said Unaudited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board. Pursuant to Regulation 33 of the SEBI (LODR) Regulations 2015 Statement showing the Unaudited Financial Results for the Second Quarter and half-year ended on 30th September 2024 along with the Limited Review Report issued by the Statutory Auditors is attached herewith.

With reference to the subject cited above we hereby inform that the Company has in compliance of Regulation of the SEBI (LODR) Regulation2015 approved the reappointment of Mr.Y.Nayudamma(DIN:00377721) as Managing Director of the Company at the 234th Board of Directors Meeting held on 13th November 2024 for a period of 3 years w.e.f 1st January 2025 to 31st December 2027. The above information is being given in terms of PARA Part A of Schedule III read with Regulation 30 of SEBI(LODR) Regulations 2015.

Pursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 13th November 2024 the Board has approved inter-alia the following items:1. Approved the Unaudited Financial Results of the company for the Second Quarter and half- year ended 30th September 2024.2. Approved the reappointment of Mr. Y. Nayudamma (DIN: 00377721) as Managing Director of the Company.The meeting commenced at 03:00 P.M. and concluded at 05:15 P.M.